Traduction de «thérapie médicale » (Français → Anglais) :

In that domain, it's of real interest in terms of public health and clinical practice because of the potential interaction of conventional medical therapies with natural therapies, which are sometimes self-prescribed.

There is a need to support the improvement of cross-cutting support technologies for drugs, biotherapies, vaccines and other therapeutic approaches, including transplantation, surgery, gene and cell therapy and nuclear medicine; to increase success in the drug and vaccine development process (including alternative methods to replace classical safety and effectiveness testing, e.g. the development of new methods); to develop regenerative medicine approaches, including approaches based on stem cells; to develop new biopharmaceuticals, including therapeutic vaccines; to develop improved medical ...[+++] and assistive devices and systems; to improve palliative therapies; to maintain and enhance the ability to combat disease and undertake medical interventions that depend on the availability of effective and safe antimicrobial drugs; and to develop comprehensive approaches to treat co-morbidities at all ages and avoid poly-pharmacy.

These new changes would attract new medical therapies to Canada, encourage real improvements to existing drugs and ensure more timely competition in the marketplace.

Appropriate use of new health therapies and technologies: long-term safety and effectiveness assessment and monitoring of large-scale use of new medical technologies (including devices) and advanced therapies to ensure a high level of protection and benefit for public health.

Acupuncture, homeopathy, massage therapy, light therapy, body work, naturopathic medicine, yoga, reflexology, Reiki, neurolinguistic programming, nutritional supplements, therapeutic touch and herbal medicines are but a few of what are now believed to be effective alternatives to traditional medical therapies.

The Committee therefore commends a series of strategies in favour of a support policy for the sector to the Commission and the European Medicines Evaluation Agency. They may be summarized as follows: - general policy: . reflecting the objectives and priorities of medical treatment; . strengthening the Commission's work to provide guidance on decisions to be made by national bodies, encouraging a process of convergence; - social policy: . a future guarantee of equal availability of medicines to all European citizens; . social protection arrangements adapted to the need for a high level of health protection; - industrial policy: . cond ...[+++]itions enabling the pharmaceutical industry to become highly competitive with its US and Japanese counterparts; . encouraging expanding employment within the sector.